Peritoneal fibrosis and high transport are induced in mildly pre-injured peritoneum by 3,4-dideoxyglucosone-3-ene in mice

Peritoneal Dialysis International

Volumn 33, Issue 2, 2013, Pages 143-154

  Yokoi, Hideki ^a   Kasahara, Masato ^a   Mori, Kiyoshi ^a   Kuwabara, Takashige ^a   Toda, Naohiro ^a   Yamada, Ryo ^b   Namoto, Shinji ^b   Yamamoto, Takashi ^b   Seki, Nana ^b   Souma, Nozomi ^b   Yamaguchi, Taku ^b   Sugawara, Akira ^a   Mukoyama, Masashi ^a   Nakao, Kazuwa ^a  

^a JMS Co Ltd   (Japan)

^b KYOTO UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

3,4 DIDEOXYGLUCOSON 3 ENE; CARBOHYDRATE DERIVATIVE; CHLORHEXIDINE GLUCONATE; MESSENGER RNA; UNCLASSIFIED DRUG;

ALPHA SMOOTH MUSCLE ACTIN GENE; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CELL INFILTRATION; COLLAGEN TYPE 1 ALPHA1 CHAIN GENE; CONCENTRATION (PARAMETERS); CONNECTIVE TISSUE GROWTH FACTOR GENE; CONTROLLED STUDY; CYTOCHROME B 245 ALPHA POLYPEPTIDE GENE; CYTOCHROME B 245 BETA POLYPEPTIDE GENE; DISEASE SEVERITY; FIBRONECTIN GENE; GENE; GENE EXPRESSION REGULATION; IN VIVO STUDY; MACROPHAGE; MEMBRANE PERMEABILITY; MOUSE; NADPH OXIDASE 1 GENE; NADPH OXIDASE 4 GENE; NEUTROPHIL CYTOSOLIC FACTOR 1 GENE; NONHUMAN; PERITONEAL FIBROSIS; PRIORITY JOURNAL; TRANSFORMING GROWTH FACTOR BETA1 GENE; UPREGULATION; VASCULAR ENDOTHELIAL GROWTH FACTOR 164 GENE;

ACTINS; ANIMALS; APOPTOSIS; CHLORHEXIDINE; DIALYSIS SOLUTIONS; DISEASE MODELS, ANIMAL; EXTRACELLULAR MATRIX; MACROPHAGES, PERITONEAL; MICE; MICE, INBRED C57BL; PERITONEAL DIALYSIS; PERITONEAL FIBROSIS; PERITONEUM; PYRONES;

EID: 84878993516     PISSN: 08968608     EISSN: 17184304     Source Type: Journal    
DOI: 10.3747/pdi.2011.00033     Document Type: Article

References (39)

1. Saxena R. Pathogenesis and treatment of peritoneal membrane failure. Pediatr Nephrol 2008; 23:695-703.
2. Yung S, Chan TM. Preventing peritoneal fibrosis-insights from the laboratory. Perit Dial Int 2003; 23(Suppl 2):S37-41.
3. Nilsson-Thorell CB, Muscalu N, Andrén AH, Kjellstrand PT, Wieslander AP. Heat sterilization of fluids for peritoneal dialysis gives rise to aldehydes. Perit Dial Int 1993; 13:208-13.
4. Linden T, Cohen A, Deppisch R, Kjellstrand P, Wieslander A. 3,4-Dideoxyglucosone-3-ene (3,4-DGE): a cytotoxic glucose degradation product in fluids for peritoneal dialysis. Kidney Int 2002; 62:697-703.
5. Erixon M, Lindén T, Kjellstrand P, Carlsson O, Ernebrant M, Forsbäck G, et al. PD fluids contain high concentrations of cytotoxic GDPs directly after sterilization. Perit Dial Int 2004; 24:392-8.
6. Williams JD, Topley N, Craig KJ, Mackenzie RK, Pischetsrieder M, Lage C, et al. The Euro-Balance Trial: the effect of a new biocompatible peritoneal dialysis fluid (Balance) on the peritoneal membrane. Kidney Int 2004; 66:408-18.
7. Schwenger V, Morath C, Salava A, Amann K, Seregin Y, Deppisch R, et al. Damage to the peritoneal membrane by glucose degradation products is mediated by the receptor for advanced glycation end-products. J Am Soc Nephrol 2006; 17:199-207.
8. Mortier S, Faict D, Lameire NH, De Vriese AS. Benefits of switching from a conventional to a low-GDP bicarbonate/lactate-buffered dialysis solution in a rat model. Kidney Int 2005; 67:1559-65.
9. Tomo T, Okabe E, Yamamoto T, Namoto S, Iwashita T, Matsuyama K, et al. Impact of 3,4-dideoxyglucosone-3-ene (3,4-DGE) on cytotoxicity of acidic heat-sterilized peritoneal dialysis fluid. J Artif Organs 2007; 10:47-51.
10. Santamaría B, Ucero AC, Reyero A, Selgas R, Ruiz-Ortega M, Catalán M, et al. 3,4-Dideoxyglucosone-3-ene as a mediator of peritoneal demesothelization. Nephrol Dial Transplant 2008; 23:3307-15.
11. Yamamoto T, Tomo T, Okabe E, Namoto S, Suzuki K, Hirao Y. Glutathione depletion as a mechanism of 3,4-dideoxyglucosone-3-ene-induced cytotoxicity in human peritoneal mesothelial cells: role in biocompatibility of peritoneal dialysis fluids. Nephrol Dial Transplant 2009; 24:1436-42.
12. Park SH, Lee EG, Kim IS, Kim YJ, Cho DK, Kim YL. Effect of glucose degradation products on the peritoneal membrane in a chronic inflammatory infusion model of peritoneal dialysis in the rat. Perit Dial Int 2004; 24:115-22.
13. Kim CD, Kwon HM, Park SH, Oh EJ, Kim MH, Choi SY, et al. Effects of low glucose degradation products peritoneal dialysis fluid on the peritoneal fibrosis and vascularization in a chronic rat model. Ther Apher Dial 2007; 11:56-64.
14. Wieczorowska-Tobis K, Brelinska R, Witowski J, Passlick-Deetjen J, Schaub TP, Schilling H, et al. Evidence for less irritation to the peritoneal membrane in rats dialyzed with solutions low in glucose degradation products. Perit Dial Int 2004; 24:48-57.
15. Oh EJ, Ryu HM, Choi SY, Yook JM, Kim CD, Park SH, et al. Impact of low glucose degradation product bicarbonate/lactate-buffered dialysis solution on the epithelial-mesenchymal transition of peritoneum. Am J Nephrol 2010; 31:58-67.
16. Yokoi H, Kasahara M, Mori K, Ogawa Y, Kuwabara T, Imamaki H, et al. Pleiotrophin triggers inflammation and increased peritoneal permeability leading to peritoneal fibrosis. Kidney Int 2012; 81:160-9.
17. Ni J, Cnops Y, Debaix H, Boisdé I, Verbavatz JM, Devuyst O. Functional and molecular characterization of a peritoneal dialysis model in the C57BL/6J mouse. Kidney Int 2005; 67:2021-31.
18. Yokoi H, Mukoyama M, Mori K, Kasahara M, Suganami T, Sawai K, et al. Overexpression of connective tissue growth factor in podocytes worsens diabetic nephropathy in mice. Kidney Int 2008; 73:446-55.
19. Yokoi H, Mukoyama M, Nagae T, Mori K, Suganami T, Sawai K, et al. Reduction in connective tissue growth factor by antisense treatment ameliorates renal tubulointerstitial fibrosis. J Am Soc Nephrol 2004; 15:1430-40.
20. Mori K, Lee HT, Rapoport D, Drexler IR, Foster K, Yang J, et al. Endocytic delivery of lipocalin-siderophore-iron complex rescues the kidney from ischemia-reperfusion injury. J Clin Invest 2005; 115:610-21.
21. Zareie M, Tangelder GJ, ter Wee PM, Hekking LH, van Lambalgen AA, Keuning ED, et al. Beneficial effects of aminoguanidine on peritoneal microcirculation and tissue remodelling in a rat model of PD. Nephrol Dial Transplant 2005; 20:2783-92.
22. Vlijm A, Sampimon DE, de Graaff M, Struijk DG, Krediet RT. Experimental peritoneal sclerosis models should not be based on chlorhexidine gluconate anymore. Nephron Exp Nephrol 2011; 117:e1-8.
23. Lai KN, Leung JC, Chan LY, Li FF, Tang SC, Lam MF, et al. Differential expression of receptors for advanced glycation end-products in peritoneal mesothelial cells exposed to glucose degradation products. Clin Exp Immunol 2004; 138:466-75.
24. Leung JC, Chan LY, Li FF, Tang SC, Chan KW, Chan TM, et al. Glucose degradation products downregulate ZO-1 expression in human peritoneal mesothelial cells: the role of VEGF. Nephrol Dial Transplant 2005; 20:1336-49.
25. De Vriese AS, Tilton RG, Stephan CC, Lameire NH. Vascular endothelial growth factor is essential for hyperglycemia-induced structural and functional alterations of the peritoneal membrane. J Am Soc Nephrol 2001; 12:1734-41.
26. Yoshio Y, Miyazaki M, Abe K, Nishino T, Furusu A, Mizuta Y, et al. TNP-470, an angiogenesis inhibitor, suppresses the progression of peritoneal fibrosis in mouse experimental model. Kidney Int 2004; 66:1677-85.
27. Tanabe K, Maeshima Y, Ichinose K, Kitayama H, Takazawa Y, Hirokoshi K, et al. Endostatin peptide, an inhibitor of angiogenesis, prevents the progression of peritoneal sclerosis in a mouse experimental model. Kidney Int 2007; 71:227-38.
28. Ksiazek K, Breborowicz A, Jörres A, Witowski J. Oxidative stress contributes to accelerated development of the senescent phenotype in human peritoneal mesothelial cells exposed to high glucose. Free Radic Biol Med 2007; 42:636-41.
29. Ksiazek K, Mikuła-Pietrasik J, Jörres A, Witowski J. Oxidative stress-mediated early senescence contributes to the short replicative life span of human peritoneal mesothelial cells. Free Radic Biol Med 2008; 45:460-7.
30. Yang AH, Chen JY, Lin JK. Myofibroblastic conversion of mesothelial cells. Kidney Int 2003; 63:1530-9.
31. Margetts PJ, Bonniaud P, Liu L, Hoff CM, Holmes CJ, West-Mays JA, et al. Transient overexpression of TGF-β1 induces epithelial mesenchymal transition in the rodent peritoneum. J Am Soc Nephrol 2005; 16:425-36.
32. Lee HB, Yu MR, Song JS, Ha H. Reactive oxygen species amplify protein kinase C signaling in high glucose-induced fibronectin expression by human peritoneal mesothelial cells. Kidney Int 2004; 65:1170-9.
33. Noh H, Kim JS, Han KH, Lee GT, Song JS, Chung SH, et al. Oxidative stress during peritoneal dialysis: implications in functional and structural changes in the membrane. Kidney Int 2006; 69:2022-8.
34. Fieren MW. Mechanisms regulating cytokine release from peritoneal macrophages during continuous ambulatory peritoneal dialysis. Blood Purif 1996; 14:179-87.
35. Sawai A, Ito Y, Mizuno M, Suzuki Y, Toda S, Ito I, et al. Peritoneal macrophage infiltration is correlated with baseline peritoneal solute transport rate in peritoneal dialysis patients. Nephrol Dial Transplant 2011; 26:2322-32.
36. Boulanger E, Wautier MP, Gane P, Mariette C, Devuyst O, Wautier JL. The triggering of human peritoneal mesothelial cell apoptosis and oncosis by glucose and glycoxydation products. Nephrol Dial Transplant 2004; 19:2208-16.
37. Welten AG, Schalkwijk CG, ter Wee PM, Meijer S, van den Born J, Beelen RJ. Single exposure of mesothelial cells to glucose degradation products (GDPs) yields early advanced glycation end-products (AGEs) and a proinflammatory response. Perit Dial Int 2003; 23:213-21.
38. Lee DH, Choi SY, Ryu HM, Kim CD, Park SH, Chung HY, et al. 3,4-Dideoxyglucosone-3-ene induces apoptosis in human peritoneal mesothelial cells. Perit Dial Int 2009; 29:44-51.
39. Catalan MP, Santamaría B, Reyero A, Ortiz A, Egido J, Ortiz A. 3,4-Di-deoxyglucosone-3-ene promotes leukocyte apoptosis. Kidney Int 2005; 68:1303-11.